105 related articles for article (PubMed ID: 27628421)
1. Influence of Genetic Polymorphisms in Prostaglandin E2 Pathway (COX-2/HPGD/SLCO2A1/ABCC4) on the Risk for Colorectal Adenoma Development and Recurrence after Polypectomy.
Pereira C; Queirós S; Galaghar A; Sousa H; Marcos-Pinto R; Pimentel-Nunes P; Brandão C; Medeiros R; Dinis-Ribeiro M
Clin Transl Gastroenterol; 2016 Sep; 7(9):e191. PubMed ID: 27628421
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.
Pereira C; Queirós S; Galaghar A; Sousa H; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
PLoS One; 2014; 9(4):e92000. PubMed ID: 24694755
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variations in Prostaglandin E
Lopes C; Pereira C; Farinha M; Medeiros R; Dinis-Ribeiro M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440718
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin transporters ABCC4 and SLCO2A1 in the uterine endometrium and conceptus during pregnancy in pigs.
Seo H; Choi Y; Shim J; Yoo I; Ka H
Biol Reprod; 2014 May; 90(5):100. PubMed ID: 24695625
[TBL] [Abstract][Full Text] [Related]
5. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients.
Bertario L; Russo A; Sala P; Pizzetti P; Ballardini G; Andreola S; Spinelli P
Int J Cancer; 2003 May; 105(1):82-7. PubMed ID: 12672034
[TBL] [Abstract][Full Text] [Related]
6. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
Ali IU; Luke BT; Dean M; Greenwald P
Br J Cancer; 2005 Oct; 93(8):953-9. PubMed ID: 16205694
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study.
Skjelbred CF; Saebø M; Wallin H; Nexø BA; Hagen PC; Lothe IM; Aase S; Johnson E; Hansteen IL; Vogel U; Kure EH
BMC Cancer; 2006 Mar; 6():67. PubMed ID: 16542436
[TBL] [Abstract][Full Text] [Related]
8. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.
Siezen CL; van Leeuwen AI; Kram NR; Luken ME; van Kranen HJ; Kampman E
Carcinogenesis; 2005 Feb; 26(2):449-57. PubMed ID: 15550453
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
[TBL] [Abstract][Full Text] [Related]
10. Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy.
Fairley KJ; Li J; Komar M; Steigerwalt N; Erlich P
Clin Transl Gastroenterol; 2014 Dec; 5(12):e64. PubMed ID: 25472702
[TBL] [Abstract][Full Text] [Related]
11. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
Chung SJ; Kim YS; Yang SY; Song JH; Kim D; Park MJ; Kim SG; Song IS; Kim JS
Gut; 2011 Nov; 60(11):1537-43. PubMed ID: 21427200
[TBL] [Abstract][Full Text] [Related]
12. COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention.
Pereira C; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
Eur J Gastroenterol Hepatol; 2010 May; 22(5):607-13. PubMed ID: 20075740
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
[TBL] [Abstract][Full Text] [Related]
14. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
16. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy.
Avidan B; Sonnenberg A; Schnell TG; Leya J; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Jun; 97(6):1524-9. PubMed ID: 12094877
[TBL] [Abstract][Full Text] [Related]
17. Dietary patterns and colorectal adenomas in Lynch syndrome: the GEOLynch cohort study.
Botma A; Vasen HF; van Duijnhoven FJ; Kleibeuker JH; Nagengast FM; Kampman E
Cancer; 2013 Feb; 119(3):512-21. PubMed ID: 23254892
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study.
Hirose M; Kono S; Tabata S; Ogawa S; Yamaguchi K; Mineshita M; Hagiwara T; Yin G; Lee KY; Tsuji A; Ikeda N
Cancer Sci; 2005 Aug; 96(8):513-8. PubMed ID: 16108833
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
